Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium

Biochemical and Biophysical Research Communications

Volumn 364, Issue 4, 2007, Pages 990-995

  Tanabe, Koichi ^a   Lamping, Erwin ^b   Adachi, Kyoko ^c   Takano, Yukie ^a   Kawabata, Kazutaka ^c   Shizuri, Yoshikazu ^c   Niimi, Masakazu ^a   Uehara, Yoshimasa ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MARINE BIOTECHNOLOGY INSTITUTE   (Japan)

Author keywords

Antifungal azole; ATP binding cassette transporter; Candida albicans; Cyclodepsipeptide; Expression system; Multi drug resistance; Pump inhibitor; Saccharomyces cerevisiae

Indexed keywords

ABC TRANSPORTER; BACTERIAL PROTEIN; CYCLOPEPTIDE; FLUCONAZOLE; RHODAMINE 6G; TACROLIMUS; UNCLASSIFIED DRUG; UNNARMICIN A; UNNARMICIN C;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; FUNGAL STRAIN; MARINE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ATP-BINDING CASSETTE TRANSPORTERS; CANDIDA ALBICANS; MARINE BIOLOGY; PEPTIDES, CYCLIC; SACCHAROMYCES CEREVISIAE;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 36048931818     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.110     Document Type: Article

References (20)

1. White T.C., Marr K.A., and Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11 (1998) 382-402
2. Maesaki S., Marichal P., Hossain M.A., Sanglard D., Vanden Bossche H., and Kohno S. Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 42 (1998) 747-753
3. Hiraga K., Yamamoto S., Fukuda H., Hamanaka N., and Oda K. Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 328 (2005) 1119-1125
4. Lee M.D., Galazzo J.L., Staley A.L., Lee J.C., Warren M.S., Fuernkranz H., Chamberland S., Lomovskaya O., and Miller G.H. Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Il Farmaco 56 (2001) 81-85
5. Lamping E., Monk B.C., Niimi K., Holmes A.R., Tsao S., Tanabe K., Niimi M., Uehara Y., and Cannon R.D. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot. Cell 6 (2007) 1150-1165
6. Niimi K., Harding D.R., Parshot R., King A., Lun D.J., Decottignies A., Niimi M., Lin S., Cannon R.D., Goffeau A., and Monk B.C. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a d-octapeptide derivative. Antimicrob. Agents Chemother. 48 (2004) 1256-1271
7. Marchetti O., Entenza J.M., Sanglard D., Bille J., Glauser M.P., and Moreillon P. Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Antimicrob. Agents Chemother. 44 (2000) 2932-2938
8. Niimi M., Wada S., Tanabe K., Kaneko A., Takano Y., Umeyama T., Hanaoka N., Uehara Y., Lamping E., Niimi K., Tsao S., Holmes A.R., Monk B.C., and Cannon R.D. Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae. Jpn. J. Infect. Dis. 58 (2005) 1-7
9. B.C. Monk, R.D. Cannon, K. Nakamura, M. Niimi, K. Niimi, D.R.K. Harding, A.R. Holmes, E. Lamping, A. Goffeau, A. Decottignies, Membrane protein expression system and its application, International patent PCT/NZ02/00163, 2002.
10. Kontoyiannis D.P., and Lewis R.E. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist. Update 6 (2003) 257-269
11. Wada S., Niimi M., Niimi K., Holmes A.R., Monk B.C., Cannon R.D., and Uehara Y. Candida glabrata ATP-binding cassette transporters Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation-dependent pumping properties. J. Biol. Chem. 277 (2002) 46809-46821
12. K. Adachi, K. Kawabata, H. Kasai, A. Katsuta, Y. Shizuri, Novel antibiotic cyclic peptides unnarmicins produced by Photobacterium, Jpn. Kokai Tokkyo Koho, JP 2007223969, 2007.
13. Albertson G.D., Niimi M., Cannon R.D., and Jenkinson H.F. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40 (1996) 2835-2841
14. Odds F.C. Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents. Antimicrob. Agents Chemother. 36 (1992)
15. Ryley J.F., Wilson R.G., and Barrett-Bee K.J. Azole resistance in Candida albicans. Sabouraudia 22 (1984) 53-63
16. Nakamura K., Niimi M., Niimi K., Holmes A.R., Yates J.E., Decottignies A., Monk B.C., Goffeau A., and Cannon R.D. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45 (2001) 3366-3374
17. Senior A.E., Al-Shawi M.K., and Urbatsch I.L. The catalytic cycle of P-glycoprotein. FEBS Lett. 377 (1995) 285-289
18. Hemenway C.S., and Heitman J. Lic4, a nuclear phosphoprotein that cooperates with calcineurin to regulate cation homeostasis in Saccharomyces cerevisiae. Mol. Gen. Genet. 261 (1999) 388-401
19. Gauthier C., Weber S., Alarco A.M., Alqawi O., Daoud R., Georges E., and Raymond M. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob. Agents Chemother. 47 (2003) 1543-1554
20. Sanglard D., Ischer F., Monod M., and Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40 (1996) 2300-2305